Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Kaplan-Meier Approach01:24

Kaplan-Meier Approach

148
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
148
Cancer Survival Analysis01:21

Cancer Survival Analysis

355
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
355
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

195
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
195
Survival Curves01:18

Survival Curves

162
Survival curves are graphical representations that depict the survival experience of a population over time, offering an intuitive way to track the proportion of individuals who remain event-free at each time point. These curves are widely used in fields such as medicine, public health, and reliability engineering to visualize and compare survival probabilities across different groups or conditions.
The Kaplan-Meier estimator is the most common method for constructing survival curves. This...
162
Actuarial Approach01:20

Actuarial Approach

79
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
79
Introduction To Survival Analysis01:18

Introduction To Survival Analysis

242
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
242

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cost-effectiveness of Pharmacist- and Nurse Practitioner-led Medication Management for Heart Failure With Reduced Ejection Fraction.

The Canadian journal of cardiology·2026
Same author

Association of ischaemic stroke/TIA with subsequent oral anticoagulant adherence in patients with atrial fibrillation: a scoping review.

BMJ open·2026
Same author

Oral anticoagulant switching in patients with atrial fibrillation: a long-term cohort study using population-level administrative data.

International journal of clinical pharmacy·2026
Same author

Characterizing Antithrombotic Regimens After Isolated Mitral Valve Repair: A Retrospective Descriptive Study and Interview of Cardiac Surgeons.

The American journal of cardiology·2026
Same author

Heart Failure Guideline-Directed Medical Therapy Scoring Systems: A Scoping Review.

Circulation. Heart failure·2026
Same author

Author Correction to "Canadian Cardiovascular Society/Canadian Heart Failure Society 2025 Guideline Update for Pharmacologic Management of Heart Failure With Nonreduced Ejection Fraction (LVEF > 40%) [Canadian Journal of Cardiology, Volume 41, Issue 10, Pages 1857-1874. DOI: 10.1016/j.cjca.2025.07.027]".

The Canadian journal of cardiology·2026

Related Experiment Video

Updated: Jul 6, 2025

Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells
09:32

Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells

Published on: February 8, 2018

14.6K

Clinician's Approach to Advanced Statistical Methods: Win Ratios, Restricted Mean Survival Time, Responder Analyses,

Melissa Lane1,2, Tyson Miao3, Ricky D Turgeon4

  • 1Lower Mainland Pharmacy Services, Vancouver, BC, Canada. Melissa.Lane@interiorhealth.ca.

Journal of General Internal Medicine
|January 3, 2024
PubMed
Summary

Clinicians need to understand novel statistical methods like win ratios and restricted mean survival time for evidence appraisal. This guide explains these methods, aiding practical application in patient care.

Keywords:
responder analysisrestricted mean survivalstandardized mean differencewin ratio

More Related Videos

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.2K
An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.1K

Related Experiment Videos

Last Updated: Jul 6, 2025

Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells
09:32

Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells

Published on: February 8, 2018

14.6K
Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.2K
An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.1K

Area of Science:

  • Medical Statistics
  • Clinical Research Methodology

Background:

  • Recent medical literature increasingly features novel statistical methods.
  • Clinicians require understanding of these methods for evidence appraisal and integration into practice.

Purpose of the Study:

  • To guide clinicians in comprehending and practically applying novel statistical methods.
  • To explain the benefits and limitations of specific statistical approaches.

Main Methods:

  • Discussion of win ratios for composite outcomes.
  • Explanation of restricted mean survival time for survival data.
  • Analysis of responder analyses for continuous outcomes.
  • Overview of standardized mean difference for meta-analysis.

Main Results:

  • Win ratios offer an alternative to composite outcomes with evidence-based prioritization.
  • Restricted mean survival time analyzes survival data when Cox model assumptions are unmet.
  • Responder analyses simplify continuous outcomes but risk information loss.
  • Standardized mean difference aids meta-analysis but requires careful interpretation.

Conclusions:

  • Understanding these statistical methods enhances clinicians' ability to critically appraise medical literature.
  • Practical application of these methods requires awareness of their benefits and limitations.
  • This guidance aims to improve evidence-based practice through statistical literacy.